2600 Via Fortuna, Suite 360, Austin, Texas, 78746, United States
Biopharmaceutical company developing innovative lung disease treatments.
Total Raised
$22 M
Rounds
2
Links
Verticals
Series A
May 2019
$8M
Apr 2018
$14M
Harlan Weisman
Chief Executive Officer
John Koleng
Vice President, Product Development and Manufacturing
Zamaneh Mikhak
Chief Medical Officer
Chris Cano
Chief Operating Officer & VP BD
